{"entity":{"type":"insider","cik":"0001591467","url":"/insider/0001591467","json_url":"/insider/0001591467.json","name":"Butler John P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":23,"first":"2014-03-27","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Butler John P.","source":"filing","n_filings":23,"first_seen":"2014-03-27","last_seen":"2026-03-05"}],"transactions":[{"id":5882048,"accession":"0001591467-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001591467-26-000003","line_url":"/filing/0001591467-26-000003#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69270.0,"shares_display":"69,270","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":86587.5,"total_display":"86,587.50","total_whole":"86,588","shares_owned_after":3367064.0,"shares_owned_after_display":"3,367,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":6076619,"accession":"0001591467-26-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001591467-26-000002","line_url":"/filing/0001591467-26-000002","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":341305.0,"shares_display":"341,305","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":474413.95,"total_display":"474,413.95","total_whole":"474,414","shares_owned_after":3206233.0,"shares_owned_after_display":"3,206,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider","n_lines":4},{"id":5139999,"accession":"0001562180-25-001998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001998","line_url":"/filing/0001562180-25-001998#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46409.0,"shares_display":"46,409","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":84928.47,"total_display":"84,928.47","total_whole":"84,928","shares_owned_after":2557921.0,"shares_owned_after_display":"2,557,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4121205,"accession":"0001562180-25-000917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-000917","line_url":"/filing/0001562180-25-000917","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144250.0,"shares_display":"144,250","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":302925.0,"total_display":"302,925.00","total_whole":"302,925","shares_owned_after":2604330.0,"shares_owned_after_display":"2,604,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider","n_lines":2},{"id":2426996,"accession":"0001562180-24-002021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-002021","line_url":"/filing/0001562180-24-002021#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46570.0,"shares_display":"46,570","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":73580.6,"total_display":"73,580.60","total_whole":"73,581","shares_owned_after":2044580.0,"shares_owned_after_display":"2,044,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider"},{"id":3184977,"accession":"0001562180-24-001992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-001992","line_url":"/filing/0001562180-24-001992#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37733.0,"shares_display":"37,733","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":57354.16,"total_display":"57,354.16","total_whole":"57,354","shares_owned_after":2091150.0,"shares_owned_after_display":"2,091,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2160707,"accession":"0001562180-24-000971","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-000971","line_url":"/filing/0001562180-24-000971#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46489.0,"shares_display":"46,489","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":78101.52,"total_display":"78,101.52","total_whole":"78,102","shares_owned_after":2128883.0,"shares_owned_after_display":"2,128,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":7802559,"accession":"0001062993-23-013664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-013664","line_url":"/filing/0001062993-23-013664#line-2","is_derivative":false,"issuer_cik":"0001591467","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001591467","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115.0,"shares_display":"115","price_per_share":0.3481,"price_display":"0.35","price_state":"stated","total_value":40.0315,"total_display":"40.03","total_whole":"40","shares_owned_after":80765.0,"shares_owned_after_display":"80,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":8449279,"accession":"0001562180-23-002201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-002201","line_url":"/filing/0001562180-23-002201","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91868.0,"shares_display":"91,868","price_per_share":0.8775,"price_display":"0.88","price_state":"stated","total_value":80614.17,"total_display":"80,614.17","total_whole":"80,614","shares_owned_after":1575242.0,"shares_owned_after_display":"1,575,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider","n_lines":3},{"id":8615507,"accession":"0001562180-23-002041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002041","line_url":"/filing/0001562180-23-002041#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38632.0,"shares_display":"38,632","price_per_share":0.8132,"price_display":"0.81","price_state":"stated","total_value":31415.5424,"total_display":"31,415.54","total_whole":"31,416","shares_owned_after":1660740.0,"shares_owned_after_display":"1,660,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":6321878,"accession":"0001062993-22-015037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-015037","line_url":"/filing/0001062993-22-015037#line-2","is_derivative":false,"issuer_cik":"0001591467","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001591467","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":53.53,"total_display":"53.53","total_whole":"54","shares_owned_after":33056.0,"shares_owned_after_display":"33,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-16","scope":"insider"},{"id":6371744,"accession":"0001562180-22-002166","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-22-002166","line_url":"/filing/0001562180-22-002166","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53973.0,"shares_display":"53,973","price_per_share":2.1707,"price_display":"2.17","price_state":"stated","total_value":117159.1911,"total_display":"117,159.19","total_whole":"117,159","shares_owned_after":1407378.0,"shares_owned_after_display":"1,407,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider","n_lines":3},{"id":6371734,"accession":"0001562180-22-002166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-002166","line_url":"/filing/0001562180-22-002166#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25053.0,"shares_display":"25,053","price_per_share":2.1548,"price_display":"2.15","price_state":"stated","total_value":53984.2044,"total_display":"53,984.20","total_whole":"53,984","shares_owned_after":1164095.0,"shares_owned_after_display":"1,164,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":5297186,"accession":"0001562180-21-002540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002540","line_url":"/filing/0001562180-21-002540#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4109.0,"shares_display":"4,109","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":13970.6,"total_display":"13,970.60","total_whole":"13,971","shares_owned_after":1152153.0,"shares_owned_after_display":"1,152,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-01","scope":"insider"},{"id":5415806,"accession":"0001562180-21-001787","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-001787","line_url":"/filing/0001562180-21-001787","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49990.0,"shares_display":"49,990","price_per_share":3.3961,"price_display":"3.40","price_state":"stated","total_value":169771.039,"total_display":"169,771.04","total_whole":"169,771","shares_owned_after":1141416.0,"shares_owned_after_display":"1,141,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider","n_lines":2},{"id":8686119,"accession":"0001562180-19-005623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005623","line_url":"/filing/0001562180-19-005623#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":172000.0,"total_display":"172,000.00","total_whole":"172,000","shares_owned_after":887732.0,"shares_owned_after_display":"887,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-21","scope":"insider"},{"id":6464150,"accession":"0001192482-18-000409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000409","line_url":"/filing/0001192482-18-000409#line-1","is_derivative":false,"issuer_cik":"0001591467","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001591467","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.4306,"price_display":"6.43","price_state":"stated","total_value":32153.0,"total_display":"32,153.00","total_whole":"32,153","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-22","filed_date":"2018-08-22","scope":"insider"},{"id":3047171,"accession":"0001140361-16-069149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-069149","line_url":"/filing/0001140361-16-069149#line-1","is_derivative":false,"issuer_cik":"0001416792","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001416792","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":19.3192,"price_display":"19.32","price_state":"stated","total_value":19570.3496,"total_display":"19,570.35","total_whole":"19,570","shares_owned_after":2849.0,"shares_owned_after_display":"2,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":8251044,"accession":"0001140361-15-024343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-024343","line_url":"/filing/0001140361-15-024343#line-1","is_derivative":false,"issuer_cik":"0001416792","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001416792","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":34.6241,"price_display":"34.62","price_state":"stated","total_value":38086.51,"total_display":"38,086.51","total_whole":"38,087","shares_owned_after":3862.0,"shares_owned_after_display":"3,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"},{"id":7076378,"accession":"0001209191-14-078216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-078216","line_url":"/filing/0001209191-14-078216#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.5672,"price_display":"11.57","price_state":"stated","total_value":11567.2,"total_display":"11,567.20","total_whole":"11,567","shares_owned_after":48350.0,"shares_owned_after_display":"48,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-29","scope":"insider"},{"id":7003667,"accession":"0001209191-14-077383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-077383","line_url":"/filing/0001209191-14-077383#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.916,"price_display":"11.92","price_state":"stated","total_value":11916.0,"total_display":"11,916.00","total_whole":"11,916","shares_owned_after":47350.0,"shares_owned_after_display":"47,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-22","scope":"insider"},{"id":6561866,"accession":"0001209191-14-076623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-076623","line_url":"/filing/0001209191-14-076623#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.3364,"price_display":"11.34","price_state":"stated","total_value":11336.4,"total_display":"11,336.40","total_whole":"11,336","shares_owned_after":46350.0,"shares_owned_after_display":"46,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-18","scope":"insider"},{"id":6808021,"accession":"0001209191-14-068410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-068410","line_url":"/filing/0001209191-14-068410#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.305,"price_display":"10.30","price_state":"stated","total_value":10305.0,"total_display":"10,305.00","total_whole":"10,305","shares_owned_after":45350.0,"shares_owned_after_display":"45,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-13","scope":"insider"},{"id":6874093,"accession":"0001209191-14-023436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-023436","line_url":"/filing/0001209191-14-023436#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591467","owner_name":"Butler John P.","owner_display_name":"Butler John P.","owner_url":"/insider/0001591467","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13850.0,"shares_display":"13,850","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":235450.0,"total_display":"235,450.00","total_whole":"235,450","shares_owned_after":13850.0,"shares_owned_after_display":"13,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director, Officer (CEO and President)","n_filings":18,"first_seen":"2014-03-27","last_seen":"2026-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Director","n_filings":3,"first_seen":"2018-08-22","last_seen":"2023-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Director","n_filings":2,"first_seen":"2015-06-15","last_seen":"2016-06-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591467","retrieved_at":"2026-08-26T04:28:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}